Crinetics Pharma COO to Step Down, Shares Weaken: Crinetics announced a COO departure on Mar 23, 2026; Nasdaq-listed CRNX saw elevated intraday volume and volatility, per Seeking Alpha and exchange data. 👈 Read full analysis #CrineticsPharma #COO #Nasdaq #CRNX #PharmaNews
0
0
0
0